VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
SSIISS Innovations International, Inc.
$3.47$694M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

SSII logoSS Innovations International, Inc.(SSII)Earnings, Financials & Key Ratios

SSII•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustrySurgical tools, endoscopy, and robotics
AboutSS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room. The company is based in Fort Lauderdale, Florida.Show more
  • Revenue$42M+105.7%
  • EBITDA-$7M+61.6%
  • Net Income-$12M+36.7%
  • EPS (Diluted)-0.06+40.0%
  • Gross Margin46%+12.4%
  • EBITDA Margin-16.75%+81.3%
  • Operating Margin-19.29%+79.0%
  • Net Margin-28.55%+69.2%
  • ROE-46.94%+66.0%

SSII Key Insights

SS Innovations International, Inc. (SSII) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓High quality earnings: Operating CF exceeds net income

✗Weaknesses

  • ✗Profits declining 60.9% over 5 years
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 12 (bottom 12%)
  • ✗Trading more than 30% below 52-week high
  • ✗Expensive at 18.0x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when SSII posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

SSII Price & Volume

SS Innovations International, Inc. (SSII) stock price & volume — 10-year historical chart

Loading chart...

SSII Growth Metrics

SS Innovations International, Inc. (SSII) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years207.7%
TTM148.24%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM48.07%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM50.83%

Return on Capital

10 Years-425.22%
5 Years-310.29%
3 Years-131.2%
Last Year-23.74%

SSII Recent Earnings

SS Innovations International, Inc. (SSII) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 0/12 qtrs (0%)●Beat Revenue 0/12 qtrs (0%)
Q2 2026Latest
May 13, 2026
Metric
Actual
Est
EPS
$0.02+0.0%
$0.02
Rev
$11M+0.0%
$11M
Q2 2026
Mar 10, 2026
Metric
Actual
Est
EPS
$0.01
—
Rev
$15M
—
Q4 2025
Oct 28, 2025
Metric
Actual
Est
EPS
$0.02
—
Rev
$13M
—
Q3 2025
Aug 7, 2025
Metric
Actual
Est
EPS
$0.00
—
Rev
$10M
—
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 13, 2026
$0.02vs $0.02+0.0%
$11Mvs $11M+0.0%
Q2 2026Mar 10, 2026
$0.01
$15M
Q4 2025Oct 28, 2025
$0.02
$13M
Q3 2025Aug 7, 2025
$0.00
$10M
Based on last 12 quarters of dataView full earnings history →

SSII Peer Comparison

SS Innovations International, Inc. (SSII) competitors in Surgical tools, endoscopy, and robotics — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
ISRG logoISRGIntuitive Surgical, Inc.Direct Competitor144.48B406.7851.6920.51%28.15%16.89%0.02
MASI logoMASIMasimo CorporationDirect Competitor9.42B179.95-64.27-27.1%4.9%9.08%0.78
AEYE logoAEYEAudioEye, Inc.Direct Competitor78.83M6.31-25.2414.52%-9.05%-70.95%2.75
RBOT logoRBOTVicarious Surgical Inc.Direct Competitor1.49M0.23-0.03-333.19%0.79
SYK logoSYKStryker CorporationProduct Competitor117.88B307.8036.6411.16%12.92%15.04%0.66
MDT logoMDTMedtronic plcProduct Competitor101.86B79.3421.983.62%13%9.49%0.59
NVCR logoNVCRNovoCure LimitedProduct Competitor1.62B14.28-11.708.28%-25.66%-50.82%0.85
ATRC logoATRCAtriCure, Inc.Product Competitor1.46B28.80-12014.88%-0.83%-0.95%0.18

Compare SSII vs Peers

SS Innovations International, Inc. (SSII) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ISRG

Most directly comparable listed peer for SSII.

Scale Benchmark

vs NVDA

Larger-name benchmark to compare SSII against a more recognizable public peer.

Peer Set

Compare Top 5

vs ISRG, MASI, AEYE, RBOT

SSII Income Statement

SS Innovations International, Inc. (SSII) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
000001.46M5.88M20.65M42.48M48.45M
Revenue Growth %
------303.19%251.2%105.74%148.24%
Cost of Goods Sold
78919.46K37.7K37.43K18.79K968.72K5.17M12.2M22.94M25M
COGS % of Revenue
-----66.43%87.87%59.07%54%-
Gross Profit
-789▲ 0%
-19.46K▼ 2366.8%
-37.7K▼ 93.7%
-37.43K▲ 0.7%
-18.79K▲ 49.8%
489.59K▲ 2706.0%
713.45K▲ 45.7%
8.45M▲ 1084.7%
19.54M▲ 131.2%
23.44M▲ 0%
Gross Margin %
-----33.57%12.13%40.93%46%48.39%
Gross Profit Growth %
--2366.79%-93.71%0.72%49.81%2706.03%45.72%1084.72%131.23%-
Operating Expenses
1.01M940.92K3.28M1.07M1.39M6.17M21.38M27.43M27.74M29.57M
OpEx % of Revenue
-----423.01%363.65%132.83%65.29%-
Selling, General & Admin
938.85K913.79K3.22M1.06M1.39M6.09M20.81M24.5M22.98M25.03M
SG&A % of Revenue
-----417.3%353.86%118.65%54.08%-
Research & Development
71.17K27.13K60.87K3K1K83.28K576.17K2.49M3.69M3.67M
R&D % of Revenue
-----5.71%9.8%12.07%8.68%-
Other Operating Expenses
0000000436K1.08M867.02K
Operating Income
-1.01M▲ 0%
-960.38K▲ 5.0%
-3.32M▼ 246.0%
-1.1M▲ 66.8%
-1.41M▼ 27.6%
-5.68M▼ 303.6%
-20.67M▼ 263.9%
-18.98M▲ 8.2%
-8.19M▲ 56.8%
-6.13M▲ 0%
Operating Margin %
------389.44%-351.52%-91.9%-19.29%-12.65%
Operating Income Growth %
-118.56%4.99%-245.98%66.81%-27.57%-303.63%-263.93%8.19%56.82%-
EBITDA
-1.01M-940.92K-3.28M-1.07M-1.39M-5.55M-20.51M-18.54M-7.12M-4.94M
EBITDA Margin %
------380.6%-348.75%-89.78%-16.75%-10.19%
EBITDA Growth %
-118.4%6.84%-249.13%67.56%-30.29%-299.81%-269.45%9.59%61.61%73.58%
D&A (Non-Cash Add-back)
78919.46K37.7K37.43K18.79K128.9K162.62K436K1.08M1.19M
EBIT
-1.01M-960.32K-3.37M-1.12M-1.48M-5.44M-20.42M-18.18M-7.05M-5.41M
Net Interest Income
-26.92K580-1.05K11877.73K-393.6K-175.24K33.09K-290.39K
Interest Income
845806118239.73K129.76K798K1.14M722.39K
Interest Expense
27K001.06K0162K523.36K973.24K1.11M1.01M
Other Income/Expense
-26.91K58-63.29K-21.75K-77.27K77.73K-273.6K-175.24K33.09K218.28K
Pretax Income
-1.04M▲ 0%
-960.32K▲ 7.5%
-3.39M▼ 252.6%
-1.12M▲ 66.8%
-1.48M▼ 32.0%
-5.6M▼ 277.4%
-20.94M▼ 273.9%
-19.15M▲ 8.6%
-8.16M▲ 57.4%
-5.91M▲ 0%
Pretax Margin %
------384.11%-356.17%-92.74%-19.21%-12.2%
Income Tax
200000003.97M4.12M
Effective Tax Rate %
-0%0%0%0%0%0%0%0%-48.6%-69.67%
Net Income
-1.04M▲ 0%
-960.32K▲ 7.5%
-3.39M▼ 252.6%
-1.12M▲ 66.8%
-1.48M▼ 32.0%
-5.6M▼ 277.4%
-20.94M▼ 273.9%
-19.15M▲ 8.6%
-12.13M▲ 36.7%
-10.03M▲ 0%
Net Margin %
------384.11%-356.17%-92.74%-28.55%-20.7%
Net Income Growth %
-113.97%7.46%-252.59%66.78%-31.98%-277.38%-273.86%8.55%36.68%48.07%
Net Income (Continuing)
-1.04M-960.32K-3.39M-1.12M-1.48M-5.6M-20.94M-19.15M-12.13M-10.03M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
-0.53▲ 0%
-0.46▲ 13.2%
-1.57▼ 241.3%
-0.48▲ 69.4%
-0.52▼ 8.3%
-1.41▼ 171.2%
-0.16▲ 88.7%
-0.10▲ 37.5%
-0.06▲ 40.0%
-0.05▲ 0%
EPS Growth %
-112%13.21%-241.3%69.43%-8.33%-171.15%88.65%37.5%40%50.83%
EPS (Basic)
-0.53-0.46-1.57-0.48-0.52-1.41-0.16-0.11-0.06-
Diluted Shares Outstanding
1.95M2.09M2.15M2.34M2.85M3.98M128.45M181.89M198.7M205.31M
Basic Shares Outstanding
1.95M2.09M2.15M2.34M2.85M3.98M128.45M170.78M190.01M196.01M
Dividend Payout Ratio
----------

SSII Balance Sheet

SS Innovations International, Inc. (SSII) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
463.03K41.55K34.76K163K408.06K4.1M18.38M27.42M48.8M66.26M
Cash & Short-Term Investments
452.57K35.72K28.47K160.71K405.77K217.18K7.03M466.5K3.21M15.98M
Cash Only
452.57K35.72K28.47K160.71K405.77K217.18K7.03M466.5K3.21M15.98M
Short-Term Investments
0000000000
Accounts Receivable
000002.49M1.65M7.16M12.4M21.32M
Days Sales Outstanding
-----623.85102.26126.52106.5297.36
Inventory
00000904.1K6.33M10.21M17.06M17.07M
Days Inventory Outstanding
-----340.65447.02305.44271.5264.3
Other Current Assets
006.29K0057.45K3.38M5.84M16.13M11.9M
Total Non-Current Assets
46.93K103.89K97.76K154.87K20.54K2.89M7.1M14.97M25.43M24.29M
Property, Plant & Equipment
3.38K35.34K84.64K38.21K20.54K1.92M2.99M8.01M11.85M11.33M
Fixed Asset Turnover
-----0.76x1.97x2.58x3.58x4.32x
Goodwill
0000000000
Intangible Assets
0013.12K1.12K036.12K36.12K000
Long-Term Investments
000115.54K002.64M3.62M9.03M21.08M
Other Non-Current Assets
43.55K68.55K000934.05K1.43M3.34M4.01M12.15M
Total Assets
509.96K▲ 0%
145.43K▼ 71.5%
132.52K▼ 8.9%
317.87K▲ 139.9%
428.61K▲ 34.8%
6.98M▲ 1528.7%
25.48M▲ 265.0%
42.39M▲ 66.4%
74.23M▲ 75.1%
90.55M▲ 0%
Asset Turnover
-----0.21x0.23x0.49x0.57x0.64x
Asset Growth %
74.51%-71.48%-8.88%139.86%34.84%1528.66%265%66.35%75.12%298.02%
Total Current Liabilities
408.87K449.78K1.2M1.19M287.28K7.77M9.27M21.33M26.24M26.05M
Accounts Payable
6.07K10.02K141.42K131.72K124.58K165.48K900.9K2.89M5.13M4.4M
Days Payables Outstanding
2.81K187.911.37K1.28K2.42K62.3563.6586.3981.5879.8
Short-Term Debt
030K457.5K195K145K6.24M6.02M15.44M579.17K576.24K
Deferred Revenue (Current)
000001.78K01.28M3.27M11.77M
Other Current Liabilities
320.3K259.76K104.04K188.7K0020.48K017.27M17.48M
Current Ratio
1.13x0.09x0.03x0.14x1.42x0.53x1.98x1.29x1.86x2.54x
Quick Ratio
1.13x0.09x0.03x0.14x1.42x0.41x1.30x0.81x1.21x1.89x
Cash Conversion Cycle
-----902.15485.63345.57296.44281.86
Total Non-Current Liabilities
000001.89M1.91M7.6M9.77M9.98M
Long-Term Debt
00000469.02K002.34M2.09M
Capital Lease Obligations
000001.37M1.91M2.35M07.06M
Deferred Tax Liabilities
0000000000
Other Non-Current Liabilities
0000010.63K074.82K288.76K7.89M
Total Liabilities
408.87K449.78K1.2M1.19M287.28K9.66M11.18M28.93M36.01M36.02M
Total Debt
015K457.5K195K145K8.27M8.22M18.2M2.92M2.66M
Net Debt
-452.57K-20.72K429.03K34.29K-260.77K8.05M1.19M17.74M-289.54K-13.32M
Debt / Equity
----1.03x-0.57x1.35x0.08x0.05x
Debt / EBITDA
----------0.54x
Net Debt / EBITDA
---------2.70x
Interest Coverage
-37.43x---1061.02x--33.58x-39.01x-18.68x-6.36x-5.34x
Total Equity
101.09K▲ 0%
-304.35K▼ 401.1%
-1.06M▼ 249.4%
-869.05K▲ 18.3%
141.33K▲ 116.3%
-2.68M▼ 1995.3%
14.3M▲ 633.8%
13.46M▼ 5.9%
38.22M▲ 184.0%
54.52M▲ 0%
Equity Growth %
128.47%-401.06%-249.35%18.27%116.26%-1995.29%633.8%-5.88%184%588.33%
Book Value per Share
0.05-0.15-0.49-0.370.05-0.670.110.070.190.27
Total Shareholders' Equity
101.09K-304.35K-1.06M-869.05K141.33K-2.68M14.3M13.46M38.22M54.52M
Common Stock
2.06K2.1K2.19K103.5K462.3K12.82K67.07K17.16K19.42K20.01K
Retained Earnings
-1.52M-2.48M-5.87M-6.99M-8.48M-3.63M-35.33M-43.66M-55.79M-59.37M
Treasury Stock
0000-26K00000
Accumulated OCI
00254.56K00954.52K704.42K150.29K-1.12M-3.57M
Minority Interest
0000000000

SSII Cash Flow Statement

SS Innovations International, Inc. (SSII) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-446.86K-443.29K-424.11K-90.54K-363.03K-5.99M-15.36M-9.5M-18.54M-14.75M
Operating CF Margin %
------411.05%-261.27%-46.02%-43.65%-
Operating CF Growth %
-134.9%0.8%4.33%78.65%-300.97%-1551.22%-156.26%38.14%-95.13%-315.3%
Net Income
-1.04M-960.32K-3.39M-1.12M-1.48M-3.21M-20.88M-19.15M-12.13M-10.03M
Depreciation & Amortization
78919.46K37.7K37.43K18.79K96.58K152.74K436K1.08M1.19M
Stock-Based Compensation
001.07M434.18K767.24K09.72M14.34M8.13M5.75M
Deferred Taxes
00000000-512.87K-448.26K
Other Non-Cash Items
218.06K-283.32K1.48M20.7K1.18M285.86K5.3M950.61K687.28K3.37M
Working Capital Changes
324.18K310.5K374.35K541.83K-849.64K-3.16M-9.66M-6.08M-15.79M-14.58M
Change in Receivables
00000-1.04M-3.07M-4.89M-13.04M-14.56M
Change in Inventory
00000-780.68K-6.11M-7.69M-8.07M-2.98M
Change in Payables
49.42K509.31K000128.84K736.08K1.41M2.88M844.02K
Cash from Investing
-4.17K-23.57K-50.12K-44K38.15K240.82K-453.33K-661.48K-3.66M-2.84M
Capital Expenditures
-4.17K-23.57K-50K-4K00-453.33K-661.48K-3.66M-2.84M
CapEx % of Revenue
-----312.6%7.71%3.2%8.61%5.86%
Acquisitions
000038.15K240.82K0000
Investments
----------
Other Investing
00-1220000000
Cash from Financing
655.38K50K466.99K266.77K569.95K5.9M22.8M9.43M26.17M21.92M
Debt Issued (Net)
-21.88K30K427.5K69.83K05.9M22.33M9.43M26.17M21.92M
Equity Issued (Net)
677.26K20K0194.84K557.05K0412.06K000
Dividends Paid
0000000000
Share Repurchases
0000-26K00000
Other Financing
0039.48K2.1K12.9K050K000
Net Change in Cash
204.35K▲ 0%
-416.86K▼ 304.0%
-7.24K▲ 98.3%
132.24K▲ 1925.9%
245.06K▲ 85.3%
-131.15K▼ 153.5%
6.81M▲ 5295.0%
-464.31K▼ 106.8%
2.98M▲ 741.7%
1.99M▲ 0%
Free Cash Flow
-451.03K▲ 0%
-466.86K▼ 3.5%
-474.23K▼ 1.6%
-94.54K▲ 80.1%
-363.03K▼ 284.0%
-1.44M▼ 295.5%
-15.81M▼ 1001.4%
-10.16M▲ 35.7%
-22.2M▼ 118.4%
-17.59M▲ 0%
FCF Margin %
------98.46%-268.98%-49.22%-52.26%-36.31%
FCF Growth %
-92.93%-3.51%-1.58%80.06%-284%-295.51%-1001.44%35.73%-118.43%-22.66%
FCF per Share
-0.23-0.22-0.22-0.04-0.13-0.36-0.12-0.06-0.11-0.09
FCF Conversion (FCF/Net Income)
0.43x0.46x0.13x0.08x0.24x1.07x0.73x0.50x1.53x1.75x
Interest Paid
003.53K1.06K000000
Taxes Paid
0000000000

SSII Key Ratios

SS Innovations International, Inc. (SSII) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
-1026.5%----1050.28%--360.46%-138%-46.94%-23%
Return on Invested Capital (ROIC)
------162.24%-148.67%-60.98%-17.78%-11.48%
Gross Margin
-----33.57%12.13%40.93%46%48.39%
Net Margin
------384.11%-356.17%-92.74%-28.55%-20.7%
Debt / Equity
----1.03x-0.57x1.35x0.08x0.05x
Interest Coverage
-37.43x---1061.02x--33.58x-39.01x-18.68x-6.36x-5.34x
FCF Conversion
0.43x0.46x0.13x0.08x0.24x1.07x0.73x0.50x1.53x1.75x
Revenue Growth
------303.19%251.2%105.74%148.24%
Related:SSII Dividend History·SSII Revenue History·SSII Price History·SSII P/E History·SSII Financial Ratios·SSII Institutional Holders

SSII SEC Filings & Documents

SS Innovations International, Inc. (SSII) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 26, 2026·SEC

Material company update

May 13, 2026·SEC

Material company update

May 7, 2026·SEC

10-K Annual Reports

2
FY 2026

Mar 10, 2026·SEC

FY 2025

Apr 15, 2025·SEC

10-Q Quarterly Reports

4
FY 2026

May 13, 2026·SEC

FY 2025

Oct 28, 2025·SEC

FY 2025

Aug 6, 2025·SEC

SSII Frequently Asked Questions

SS Innovations International, Inc. (SSII) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

SS Innovations International, Inc. (SSII) reported $48.4M in revenue for fiscal year 2025.

SS Innovations International, Inc. (SSII) grew revenue by 105.7% over the past year. This is strong growth.

SS Innovations International, Inc. (SSII) reported a net loss of $10.0M for fiscal year 2025.

Dividend & Returns

SS Innovations International, Inc. (SSII) has a return on equity (ROE) of -46.9%. Negative ROE indicates the company is unprofitable.

SS Innovations International, Inc. (SSII) had negative free cash flow of $17.6M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in SSII back in 2016?

Total return calculator · dividends reinvested · 10+ years of data

See returns →

How much would $100/month in SSII be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →